Company intelligence / Profile preview

Nimes Capital

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

Nimes Capital is a private investment firm and family office that serves as the investment arm of Nazarian Enterprises. The firm invests across multiple sectors rather than operating as a drug developer, with publicly described focus areas including real estate, hospitality, wireless and broadband, clean technology, infrastructure, manufacturing, and technology. Available public sources describe Nimes Capital as an active private investor based in Los Angeles, California, led by founder and CEO David Nazarian. There is no evidence that Nimes Capital is a life science, biotech, pharma, or healthcare operating company, nor that it maintains a therapeutic pipeline.

Industry: Investors

Beyond the preview

Go deeper on Nimes Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nimes Capital.

Explore the full profile